Company intelligence / Profile preview

Excell Biotech

Clearwater, Florida, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Excell Biotech was a private U.S. biotechnology startup based in Clearwater, Florida focused on genomics-based therapeutics for viral infection and immune disease. Public materials described the company as developing vaccines and gene therapies, with its lead disclosed program being EXD-12, a live attenuated herpes simplex virus vaccine in preclinical development. The company also described earlier-stage oncology work intended to restore p53 activity in cancer cells and broader gene therapy ambitions for genetic diseases. Third-party company databases later classified the company as inactive or deadpooled, suggesting operations have ceased.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: VaccineGene therapy
Industry: Biotech

Drug pipeline

1 asset

EXD-12

Preclinical

Beyond the preview

Go deeper on Excell Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excell Biotech.

Explore the full profile